A rare genetic condition called vitamin D-dependent rickets type 2A causes children’s bodies to ignore vitamin D signals, leading to weak bones despite high vitamin D levels. According to Gram Research analysis, a 2026 case report identified a 9-month-old with this condition through genetic testing after standard rickets treatment failed. The child had a mutation in the vitamin D receptor gene that blocked vitamin D’s effects. High-dose vitamin D therapy resulted in improved blood chemistry and catch-up growth, showing that early genetic diagnosis enables effective treatment.
A 9-month-old child presented with poor growth and weak bones, initially misdiagnosed with a common form of rickets. According to Gram Research analysis, genetic testing revealed a rare condition called vitamin D-dependent rickets type 2A, where the body can’t use vitamin D properly despite having plenty of it. This case study shows how doctors can miss this diagnosis when calcium levels appear normal. With high-dose vitamin D treatment, the child improved significantly. The findings highlight the importance of checking vitamin D hormone levels and using genetic testing when standard rickets treatments don’t work.
Key Statistics
A 2026 case report in JCEM Case Reports documented a 9-month-old child with vitamin D-dependent rickets type 2A caused by a homozygous VDR gene mutation (c.1027C>T) who showed progressive biochemical improvement and catch-up growth after high-dose calcitriol therapy.
The case demonstrated that vitamin D-dependent rickets type 2A can present with normal calcium levels and elevated 1,25-dihydroxyvitamin D (active vitamin D hormone), leading to initial misdiagnosis as hypophosphatemic rickets before genetic testing confirmed the correct diagnosis.
A child with vitamin D-dependent rickets type 2A showed markedly elevated alkaline phosphatase and hypophosphatemia despite normocalcemia, highlighting that this rare genetic condition may not present with the typical low calcium levels expected in rickets.
The Quick Take
- What they studied: A rare genetic condition where children’s bodies can’t respond to vitamin D properly, even when vitamin D levels are high, causing weak and soft bones
- Who participated: One 9-month-old child from Middle Eastern parents who presented with slow growth and poor weight gain
- Key finding: The child had high levels of active vitamin D hormone but couldn’t use it because of a genetic mutation in the vitamin D receptor gene, causing bone weakness without the low calcium levels doctors typically expect
- What it means for you: If a child has rickets (weak bones) that doesn’t improve with standard vitamin D treatment, doctors should test for this rare genetic condition. High-dose vitamin D therapy can help, but genetic testing is needed for accurate diagnosis.
The Research Details
This is a case report describing one child with a rare genetic bone disease. The doctors carefully tracked the child’s blood tests, bone imaging, and growth over time while trying different treatments. When standard treatments didn’t work, they performed genetic testing (whole-exome sequencing) to identify the exact genetic mutation causing the problem.
The child started with symptoms at 9 months old including poor growth and weight gain. Initial blood work showed normal calcium but low phosphate levels, high parathyroid hormone, and very high alkaline phosphatase (an enzyme related to bone health). Bone X-rays showed rickets. The doctors first thought this was a common type of rickets caused by low phosphate, but the child didn’t improve with standard treatment.
Further testing revealed extremely high levels of active vitamin D hormone (1,25-dihydroxyvitamin D), which was unusual. Genetic testing found a mutation in the vitamin D receptor gene that prevented the body from responding to vitamin D. Once doctors understood the problem, they increased the vitamin D dose significantly, and the child improved.
This case is important because it shows how a rare genetic condition can look like a more common disease at first. Doctors might miss the diagnosis and give ineffective treatment. By recognizing the pattern of high vitamin D hormone levels with persistent bone problems, doctors can order genetic testing earlier and start the right treatment sooner.
This is a single case report, which is the lowest level of research evidence. However, case reports are valuable for describing rare diseases and unusual presentations. The diagnosis was confirmed with genetic testing, which is very reliable. The child’s response to high-dose treatment supports the diagnosis. Readers should understand this describes one child’s experience and may not apply to all cases of this rare condition.
What the Results Show
The child presented at 9 months with poor growth and inadequate weight gain. Blood tests showed normal calcium levels (which was unusual), but low phosphate, high parathyroid hormone, and very high alkaline phosphatase. Bone X-rays confirmed rickets. Initial treatment with standard doses of vitamin D, calcium, phosphate, and bicarbonate did not improve the child’s condition.
Genetic testing revealed a homozygous mutation (meaning the child inherited the same mutation from both parents) in the vitamin D receptor gene: c.1027C>T (p.R343C). This mutation prevents the body’s cells from responding to vitamin D hormone, even when levels are very high. This is the defining feature of vitamin D-dependent rickets type 2A.
When doctors increased the vitamin D dose significantly (high-dose calcitriol therapy), the child’s blood chemistry gradually improved. Phosphate levels increased, parathyroid hormone decreased, and alkaline phosphatase normalized. Most importantly, the child experienced catch-up growth, meaning the growth rate increased to make up for the earlier slow growth period.
The case demonstrates that vitamin D-dependent rickets type 2A can present differently than expected. Typically, doctors expect to see low calcium levels in rickets, but this child had normal calcium despite severe bone disease. This unusual presentation led to initial misdiagnosis as hypophosphatemic rickets (a different type of rickets caused by low phosphate). The markedly elevated vitamin D hormone level was the key clue that suggested a different diagnosis.
Vitamin D-dependent rickets type 2A is a well-known but rare genetic condition. This case adds to the medical literature by showing that the condition can present with normal calcium levels, which is not the typical presentation. Previous cases have usually shown low calcium levels. This finding helps doctors recognize the condition earlier in children who don’t fit the typical pattern. The genetic mutation identified (R343C) in the vitamin D receptor has been reported in other cases, confirming it is a known disease-causing variant.
This is a single case report, so the findings apply to this one child and may not represent all cases of this rare condition. Case reports cannot prove cause-and-effect relationships or determine how common certain features are. The child’s response to treatment is encouraging but doesn’t prove that all children with this mutation will respond the same way. Additionally, the case does not include long-term follow-up data beyond the initial treatment response, so we don’t know about the child’s development over years.
The Bottom Line
Children with rickets (weak or soft bones) that don’t improve with standard vitamin D treatment should be evaluated for vitamin D-dependent rickets type 2A. This evaluation should include checking vitamin D hormone levels (1,25-dihydroxyvitamin D) and considering genetic testing. If this condition is diagnosed, high-dose vitamin D therapy (calcitriol) can be effective. These recommendations are based on case reports and clinical experience rather than large studies, so doctors should individualize treatment for each child.
Parents of children with rickets that doesn’t respond to standard treatment should be aware of this rare condition. Pediatricians and pediatric endocrinologists should consider this diagnosis when they see rickets with normal calcium levels or when standard treatment fails. Genetic counselors may be involved in families with this condition. This condition is rare, so most children with rickets have other causes, but awareness helps ensure accurate diagnosis for those who do have it.
In this case, the child showed biochemical improvement (blood test changes) within weeks to months of starting high-dose vitamin D therapy. Catch-up growth (accelerated growth to make up for lost time) began after biochemical improvement. Full recovery of bone health typically takes months to years depending on the severity of the initial disease and how quickly treatment starts. Early diagnosis and treatment lead to better outcomes.
Frequently Asked Questions
What is vitamin D-dependent rickets type 2A and how is it different from regular rickets?
Vitamin D-dependent rickets type 2A is a rare genetic condition where the body can’t respond to vitamin D because of a mutation in the vitamin D receptor gene. Unlike regular rickets caused by low vitamin D or calcium, this condition occurs when vitamin D levels are actually very high, but the body ignores the signal. Genetic testing is needed to diagnose it.
Why didn’t standard vitamin D treatment work for this child?
Standard vitamin D doses don’t work because the child’s body cells cannot respond to vitamin D due to the genetic mutation. The vitamin D receptor is broken, so adding more regular vitamin D doesn’t help. High-dose vitamin D (calcitriol) therapy was needed to overcome the resistance and improve bone health.
How common is vitamin D-dependent rickets type 2A in children?
Vitamin D-dependent rickets type 2A is very rare. Most children with rickets have other causes like low vitamin D intake or kidney disease. This case report describes one child, so exact prevalence is unknown, but it’s considered an uncommon genetic disorder that requires genetic testing to diagnose.
What should parents do if their child has rickets that doesn’t improve with treatment?
Parents should ask their pediatrician about checking vitamin D hormone levels (1,25-dihydroxyvitamin D) and considering genetic testing. If standard vitamin D treatment isn’t working after several months, evaluation by a pediatric endocrinologist is recommended to identify rare genetic causes like vitamin D-dependent rickets type 2A.
Can children with this condition grow normally with treatment?
Yes, according to this case report, high-dose vitamin D therapy led to catch-up growth, meaning the child’s growth rate increased significantly after treatment started. With early diagnosis and appropriate high-dose therapy, children can achieve normal growth and bone health, though long-term outcomes require ongoing monitoring.
Want to Apply This Research?
- Track monthly growth measurements (height and weight percentiles) and quarterly blood phosphate and alkaline phosphatase levels to monitor response to vitamin D therapy in children with this condition
- Set reminders for high-dose vitamin D medication administration and schedule regular follow-up appointments with pediatric endocrinologists to monitor biochemical markers and growth progress
- Create a long-term tracking dashboard showing growth curves, blood test trends, and medication compliance over 12-24 months to assess treatment effectiveness and adjust therapy as needed
This case report describes one child’s experience with a rare genetic condition. It is not medical advice and should not replace consultation with a qualified pediatrician or pediatric endocrinologist. Rickets has many causes, and this rare genetic form requires specialized diagnosis and treatment. If your child has symptoms of rickets or bone disease, consult with a healthcare provider for proper evaluation and personalized treatment recommendations. Genetic testing should only be performed under medical supervision with appropriate genetic counseling.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.